Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
- The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with global rights. - This approval in China marks the third regulatory clearance granted to ATG-101 globally. - Upon receiving clearances in Australia and the U.S. in 2021, the Phase I study of ATG-101 was subsequently initiated in Australia...
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric...
SUZHOU, China, March 10, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta has presented the safety/tolerability and preliminary anti-tumor activity data in gastric and pancreatic cancers of TST001 China phase I clinical trial as a poster presentation at...
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting
The abstract of BBT-207 pre-clinical studies is now available at the AACR website Preclinical data suggests that BBT-207 may have the potential to be positioned as a frontline treatment with the anti-tumor effects in EGFR mutant NSCLC SEONGNAM, South Korea, March 10, 2022 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company focused...
Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific
SINGAPORE, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched the Know Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score as a gauge of their kidney health, reinforcing the idea that "knowing your score can save your life"....
Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Malaysia
KUALA LUMPUR, Malaysia, March 10, 2022 /PRNewswire/ -- Baxter Malaysia, a global leader in dialysis care, has launched the Know Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score as a gauge of their kidney health, reinforcing the idea that "knowing your score can save...
Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico’s generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis
- Cystinosis is a rare genetic disease affecting 1 in 100,000-200,000 live births and poses a lifelong risk to those affected. Cystinosis slowly destroys the body's organs including the kidneys, eyes, thyroid, muscles, liver, pancreas, gonads, and brain. - There are currently no curative treatments for cystinosis. - The Mechanisms of Inherited Kidney Disorders (MIKADO) group at the University...
Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin
Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri, Sofwave's CEO: "We are proud to report a sharp revenue growth to $21.8 million in 2021, with a...
Databricks Introduces Lakehouse for the Healthcare and Life Sciences Industries to Drive Transformation Across Healthcare Ecosystem
As the industry begins to embrace the power of AI, the lakehouse brings patient, research, and operational data together at scale to deliver new innovations in research and care SAN FRANCISCO, March 9, 2022 /PRNewswire/ -- Databricks, the Data and AI company and pioneer of the data lakehouse paradigm, today launched the...
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan aiming to provide genetic testing to clinicians, is the first institution in Asia Pacific to adopt SOPHiA GENETICS' technology to support...
NCCN Expands Resources for Treating Rare Cancer Types
The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes for these rare tumor types; also reaches milestone expanding library of NCCN Chemotherapy Order Templates. PLYMOUTH MEETING, Pa., March 9, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance...
